National Cancer Center of China | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

556,609 results for “National Cancer Center of China”

Trials

View all 503943 →

Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing

39 participants · First posted Nov 24, 2023

Mapping of Lymph Node Metastasis and Survival For pN+ Superficial Esophageal Squamous Cell Carcinoma

207 participants · First posted Sep 2, 2022

Prospective National Multi-center Registry of Obstructive Sleep Apnea Syndrome in Hypertensive Patients in China

633 participants · First posted Feb 21, 2023

Drugs

View all 6845 →

Fecal Microbiota Transplantation（German Cancer Research Center）

KrasG12D siRNA-loaded mesenchymal stromal cells-derived exosomes (Codiak BioSciences)

c-myb AS ODN

Organizations

View all 4867 →

NATIONAL CANCER CENTER

Japan

NATIONAL CANCER CENTER HOSPITAL

Japan

National Cancer Center Korea

South Korea

News

View all 40954 →

Circulating Tumor DNA Monitoring Enables Personalized Immunotherapy in Limited-Stage Small Cell Lung Cancer

Hypofractionated Radiotherapy Reduces Treatment Time and Toxicity While Maintaining Survival in Limited-Stage Small Cell Lung Cancer

Leads Biolabs' PD-L1/4-1BB Bispecific Opamtistomig Delivers 71% ORR in First-Line NSCLC at WCLC 2026

Page 1 of 55661